McKesson Corporation logo

McKesson Corporation (M1CK34)

Market Closed
B3 B3
R$
R$
- Market Cap
17.39 P/E Ratio
2.84% Div Yield
- Volume
25.95 Eps
R$
Previous Close
Day Range
0 0
Year Range
0 0
Want to track M1CK34 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 12 days

Summary

M1CK34 is not paying dividends to its shareholders.
The last earnings report, released on May 08, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports. The next scheduled earnings report is due on Aug 05, 2025.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on B3 (BRL).

M1CK34 Chart

Chart

Chart with 60 data points.
The chart has 1 X axis displaying categories.
The chart has 2 Y axes displaying values, and values.
End of interactive chart.

McKesson Corporation Dividends

McKesson Corporation logo
M1CK34 1 month ago
Other
R$0.7 Per Share
McKesson Corporation logo
M1CK34 4 months ago
Other
R$0.71 Per Share
McKesson Corporation logo
M1CK34 7 months ago
Other
R$0.76 Per Share
McKesson Corporation logo
M1CK34 10 months ago
Other
R$0.67 Per Share
McKesson Corporation logo
M1CK34 31 May 2024
Other
R$0.61 Per Share

McKesson Corporation Earnings

5 Aug 2025 (In 1 week) Date
-
Cons. EPS
-
EPS
8 May 2025 Date
-
Cons. EPS
-
EPS
5 May 2025 Date
-
Cons. EPS
-
EPS
McKesson Corporation logo
M1CK34 1 month ago
Other
R$0.7 Per Share
McKesson Corporation logo
M1CK34 4 months ago
Other
R$0.71 Per Share
McKesson Corporation logo
M1CK34 7 months ago
Other
R$0.76 Per Share
McKesson Corporation logo
M1CK34 10 months ago
Other
R$0.67 Per Share
McKesson Corporation logo
M1CK34 31 May 2024
Other
R$0.61 Per Share
5 Aug 2025 (In 1 week) Date
-
Cons. EPS
-
EPS
8 May 2025 Date
-
Cons. EPS
-
EPS
5 May 2025 Date
-
Cons. EPS
-
EPS

McKesson Corporation (M1CK34) FAQ

What is the stock price today?

The current price is R$0.00.

On which exchange is it traded?

McKesson Corporation is listed on B3.

What is its stock symbol?

The ticker symbol is M1CK34.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 2.84%.

What is its market cap?

As of today, no market cap data is available.

When is the next earnings date?

The next earnings report will release on Aug 05, 2025.

Has McKesson Corporation ever had a stock split?

No, there has never been a stock split.

McKesson Corporation Profile

Medical - Distribution Industry
Healthcare Sector
Brian S. Tyler CEO
B3 Exchange
- ISIN
US Country
44,000 Employees
30 May 2025 Last Dividend
- Last Split
15 Nov 1994 IPO Date

Overview

McKesson Corporation stands as a prominent provider of healthcare services not only within the United States but also on an international platform. With its foundation laid in 1833, the company has excelled in extending its footprint across various segments of the healthcare industry, making it headquartered in Irving, Texas. Operating through four main segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International, McKesson strives to address the variegated needs of the healthcare realm. These segments collaborate to distribute pharmaceuticals, offer technological and clinical solutions, and ensure necessary medical supplies reach healthcare providers efficiently.

Products and Services

  • U.S. Pharmaceutical:
  • This segment is instrumental in distributing a vast array of pharmaceuticals, including branded, generic, specialty, biosimilar, and over-the-counter drugs. Furthermore, it caters to community-based oncology and other specialty practices by supplying practice management, technology, clinical support, and business solutions. Additionally, it encompasses services like consulting, outsourcing, technological offerings, and providing financial, operational, and clinical solutions targeted at pharmacies.

  • Prescription Technology Solutions (RxTS):
  • Under this banner, McKesson takes a significant step towards bridging the medication-related gaps between biopharma, life sciences partners, and patients by interlinking patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. The RxTS segment aims at rolling out innovative solutions to streamline the process of medication acquisition, ensuring the delivery of medicine that enriches patient health. Services rendered include prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support.

  • Medical-Surgical Solutions:
  • This segment ensures the streamlined distribution of medical and surgical supplies, logistics, and other pivotal services to various healthcare settings, encompassing physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. It represents McKesson's commitment to providing essential supplies and services that support the health ecosystem's backbone, thereby enabling healthcare providers to deliver quality care.

  • International:
  • McKesson's International segment focuses on the distribution of pharmaceuticals and medical supplies, along with rendering services to a vast customer base, including wholesale, institutional, and retail channels across Europe and Canada. This segment showcases the company's dedication to extending its healthcare services and products to a global audience, ensuring an international footprint in healthcare distribution and services.

Contact Information

Address: 6555 State Highway 161
Phone: 972 446 4800